INSIGHT MEDICAL WRITING LIMITEDActive
Key figures
Ratios
2025Balance sheet structure
Filed accounts2019/20–2025
| 2019/20 | 2021 | 2022 | 2023 | 2025 | |
|---|---|---|---|---|---|
| Turnover | 5,054,129 | 3,145,485 | — | — | 125,332 |
| Profit for the year | 1,197,357 | 444,150 | — | 1,340,819 | — |
| Cash at bank and in hand | 1,386,969 | 2,360,525 | 6,697,548 | 3,165,129 | 1,523,669 |
| Total assets | 5,030,883 | 6,470,757 | 9,317,273 | 9,097,014 | 8,457,440 |
| Total liabilities | 1,080,268 | 1,030,165 | 2,569,861 | 1,008,783 | 421,945 |
| Net assets / total equity | 3,934,487 | 5,449,399 | 6,759,780 | 8,100,599 | 8,035,495 |
| Average number of employees | 31 | 26 | 3 | 2 | 2 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025The principal activity of the Company is the provision of medical writing services for the pharmaceutical industry
As described in the company's latest filed accounts.
Summary: INSIGHT MEDICAL WRITING LIMITED
Company
INSIGHT MEDICAL WRITING LIMITED is a private limited company registered with Companies House under company number 04214826. It was incorporated on 11 May 2001. Its status is active. The registered office is in Oxon (OX5). Its nature of business (SIC 2007) is other human health activities (86900).
Accounts
The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts (filleted). Turnover was £125,332. Net assets were £8,035,495, down 0.8% on the previous year. Cash at bank and in hand was £1,523,669. Total assets were £8,457,440 and total liabilities £421,945. The company had an average of 2 employees. Figures are available for 5 financial years (2019/20–2025).
Control and charges
One person with significant control is registered. 2 of 2 registered charges are outstanding.
Filing deadlines
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 25 May 2027.